期刊文献+

前列排瘀法治疗慢性盆腔疼痛综合征临床研究 被引量:1

Clinical Research of Eliminating Sedimentation on Treating Chronic Pelvic Pain Syndrome
下载PDF
导出
摘要 目的:观察前列排瘀法治疗慢性盆腔疼痛综合征(CPPS)疗效及NIH—CPSI评分。方法:据NIH前列腺炎综合征分类标准,选择CPPS病例719例,根据EPSRt(前列腺液常规)分成Ⅲa和Ⅲb两组。721例均采用示指一指禅功前列排瘀法治疗,每3 d 1次,一次3~5 min,10次为1疗程。排瘀法治疗前、治疗后作EPSRt及NIH—CPSI评分进行疗效评价。结果:3个疗程后Ⅲa组显效率18.2%,有效率66.1%;Ⅲb组显效率16.1%,有效率69.6%。经统计分析,治疗前后差异有统计学意义(P<0.01)。两组间疗效差异无统计学意义(P>0.05)。每一疗程结束后,两组NIH-CPSI各类得分均有明显改善(P<0.01)。结论:前列排瘀法有排瘀散结,通利腺管,最终排出瘀浊的作用。能有效改善或消除盆腔疼痛综合征症状,提高生活质量。 Objective : To explore the curative effects of the way by eliminating sedimentation from prostate with manipulation on treating chronic pelvic pain syndrome(CPPS) and the National Institutes of Health (NIH) -chronic prostatitis symptom index(CPSI) scores. Methods:According to the prostatitis classification standard of NIH,719 cases with CPPS were divided into Ⅲ A arid Ⅲ B group by EPSRt and treated with manipulation. EPSRt and NIH - CPSI scores were tested before treatment and each periods after treatment. Results : After three periods of treatment, the effective ratio and total effective ratio of ⅢA were 18.2 % and 66.1% respectively. Those of Ⅲ B were 16.1% and 69.6% respectively. Statistical analysis showed the curative effect of two groups without a significant difference( P 〉 0.05 ). NIH -CPSI scores of two groups had'significant improvement after each period of treatment (P 〈 0.01 ). Conclusion:The way by eliminating sedimentation can improve the clinical symptom of CPPS and life quality, and it also (:an disperse the nub, discharge the turbid and clear the gland in order to eliminate sedimentation,and relieve sinus hyperaemia around the prostate.
出处 《中华中医药学刊》 CAS 2013年第3期678-681,共4页 Chinese Archives of Traditional Chinese Medicine
关键词 慢性盆腔疼痛综合征 前列腺 一指禅功 推拿 排瘀法 NIH—CPSI评分 chronic pelvic pain syndrome (CPPS) prostate single - finger manipulation Tuina eliminating sedimentation NIH - CPSI score
  • 相关文献

参考文献8

二级参考文献14

  • 1夏同礼,中华泌尿外科杂志,1995年,16卷,12期,711页
  • 2Shoskes DA. Use of antibiotics in chronic prostates syndromes. Can J Urol,2001,8:24-28.
  • 3Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostates : consensus report from the first National Institutes of Health International Prostatis Collaborative Network. Urology, 1999,54(2) :229-233.
  • 4Nickel JC, Downey J, Johnston B, et al. Predictors of patient response to antibiotic therapy for the chronic prosatitis/chronic pelvic pain syndrome:a prospective multicenter clinical trial. J Urol,2001,165(5) :1593-1644.
  • 5Zermann DH, Ishigooda M, Doggweiler Wiygul R, et al. The male chronic pelvic pain syndrome. World J Urol, 2001,19 (3) :173-179.
  • 61,Roberts R O, Lieber M M, Bostewick D G, et al. A review of clinical andpathological prostatitis syndromes. Urology,1997,49:809~821
  • 72,Brunner H, Weidner W, Sshiefer H G.Studies of the role of Ureaplasma urealyticum andmycoplasma hominis in prostatitis.J Infect Dis,1983,147:807~813
  • 83,Schaeffet A J, Darras F S. The efficacy of norfloxacin in the treatment of chronicbacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. JUrol,1990, 144:690~693
  • 94,Nickel J C, Downey J, Clark J, et al. Antibiotic pharmacokinetics in the inflamedprostate. J Urol,1995,153:527~529
  • 10田中英寿.舍尼通治疗前列腺炎の临床疗效[J].泌尿纪要,1992,38:489-494.

共引文献110

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部